Perspectives on telemedicine visits reported by patients with cancer Journal Article
| Authors: | Doshi, S. D.; Khadem Charvadeh, Y.; Seier, K.; Bange, E. M.; Daly, B.; Lipitz-Snyderman, A.; Polubriaginof, F. C. G.; Buckley, M.; Kuperman, G.; Stetson, P. D.; Schrag, D.; Morris, M. J.; Panageas, K. S. |
| Article Title: | Perspectives on telemedicine visits reported by patients with cancer |
| Abstract: | Importance: The COVID-19 pandemic catalyzed rapid adoption of telemedicine visits for cancer care delivery. However, patients' experiences with telemedicine remain poorly understood. Objective: To understand patients' satisfaction with telemedicine visits at a comprehensive cancer center. Design, Setting, and Participants: This survey study included patients with cancer at a US cancer center between 2020 and 2023. Eligible patients completed surveys in English conducted after their first telemedicine appointment via an online patient portal. Data were analyzed between January and June 2024. Exposures: Patient surveys about telemedicine experiences, with a specific comparison with an in-person visit. Structured items elicited satisfaction with the specific visit, preferences for future use of telemedicine, and technical ease of use; unstructured free-text responses were also elicited. Main Outcomes and Measures: Proportion of patients who indicated that telemedicine visits were superior or preferred to in-person visits. Secondary outcomes included multivariable analysis of barriers to telemedicine use and variations in patient experiences by demographic characteristics over the observation period, and free-text analysis of unstructured responses describing the telemedicine experience using the BERTopic algorithm and a language model. Results: A total of 27 435 telemedicine users completed surveys from May 2020 to October 2023 (median [IQR] age, 65 [55-72] years; 15 072 female [54.9%]; 1771 Asian [6.7%], 1339 Black [5.1%], 22 742 White [85.9%]). Overall, 18 025 of 24 418 patients (73.8%) rated their first telemedicine visit as good as or better than an in-person visit, and 4606 (18.9%) rated it superior to an in-person visit. The proportion of patients rating a telemedicine visit superior to an in-person visit evolved from 17% in 2020 to 20% in 2023. Structured questions revealed a positive view of telemedicine, while free-text analyses highlighted issues with technology. Conclusions and Relevance: In this survey study of perspectives on telemedicine visits, a large majority of patients at a comprehensive cancer center expressed satisfaction with telemedicine visits in proportions that remained consistent beyond the end of the pandemic. These findings challenge health care systems to integrate telemedicine into routine cancer care and to overcome remaining technical challenges and barriers to ease of use. |
| Keywords: | adult; aged; middle aged; patient satisfaction; united states; neoplasm; neoplasms; psychology; questionnaire; therapy; telemedicine; pandemic; humans; human; male; female; surveys and questionnaires; pandemics; severe acute respiratory syndrome coronavirus 2; coronavirus disease 2019; covid-19; sars-cov-2 |
| Journal Title: | JAMA Network Open |
| Volume: | 7 |
| Issue: | 11 |
| ISSN: | 2574-3805 |
| Publisher: | American Medical Association |
| Date Published: | 2024-11-01 |
| Start Page: | e2445363 |
| Language: | English |
| DOI: | 10.1001/jamanetworkopen.2024.45363 |
| PUBMED: | 39546309 |
| PROVIDER: | scopus |
| PMCID: | PMC11568458 |
| DOI/URL: | |
| Notes: | Article -- MSK Cancer Center Support Grant (P30 CA008748) acknowledged in PDF -- MSK corresponding author is Sahil Doshi -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work